The role of somatostatin analogs in the management of carcinoid tumors.
Tomassetti
P
P
Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy. paola.tomassetti@unibo.it
Migliori
M
M
Campana
D
D
Brocchi
E
E
Piscitelli
L
L
Tomassetti
V
V
Corinaldesi
R
R
D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002276:Carcinoid Tumor / Q000188:drug therapy*; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage; D016898:Interferon-alpha / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000188:drug therapy*; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D011788:Quality of Life; D013004:Somatostatin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
D018931:Antineoplastic Agents, Hormonal; D007155:Immunologic Factors; D016898:Interferon-alpha; D013004:Somatostatin